Compile Data Set for Download or QSAR
Report error Found 62 Enz. Inhib. hit(s) with all data for entry = 9639
TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477630(US10889569, Example 9 | 5-(3-(3-(6-Fluorobenzo[b]t...)
Affinity DataIC50: 1.20E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477658(US10889569, Example 26 | 1-(1-(5-(Ethoxymethyl)-4-...)
Affinity DataIC50: 1.40E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477653(US10889569, Example 37 | 4-(1-(5-((Difluoromethoxy...)
Affinity DataIC50: 1.70E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477638(US10889569, Example 19 | 5-Fluoro-1-(1-(5-(methoxy...)
Affinity DataIC50: 2.00E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477654(US10889569, Example 39 | 6-Fluoro-1-(1-(4-(6-metho...)
Affinity DataIC50: 2.00E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477651(US10889569, Example 36 | Methyl ((5-(3-(6-fluoro-3...)
Affinity DataIC50: 2.10E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477626(US10889569, Example 4 | 3-Chloro-1-(1-(5-(ethoxyme...)
Affinity DataIC50: 2.30E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477633(US10889569, Example 11 | 5-(3-(3-(6-Fluorobenzofur...)
Affinity DataIC50: 2.30E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477644(US10889569, Example 28 | 1-(1-(4-(Benzo[d][1,3]dio...)
Affinity DataIC50: 2.40E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477640(US10889569, Example 21 | 5-(3-(3-(7-Fluorobenzodih...)
Affinity DataIC50: 2.70E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477639(US10889569, Example 20 | 5-Fluoro-1-(1-(4-(6-metho...)
Affinity DataIC50: 3.10E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477648(US10889569, Example 31 | 4-(1-(5-(Ethoxymethyl)-4-...)
Affinity DataIC50: 3.50E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477636(US10889569, Example 17 | 5-Fluoro-1-(1-(5-(methoxy...)
Affinity DataIC50: 4.40E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477656(US10889569, Example 42 | 6-Fluoro-1-(1-(5-(methoxy...)
Affinity DataIC50: 4.50E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477624(US10889569, Example 2 | 5-(3-(3-(6-Fluoronaphthale...)
Affinity DataIC50: 4.50E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477627(US10889569, Example 6 | 5-Fluoro-1-(1-(4-(6-methox...)
Affinity DataIC50: 4.70E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477624(US10889569, Example 2 | 5-(3-(3-(6-Fluoronaphthale...)
Affinity DataIC50: 4.90E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477626(US10889569, Example 4 | 3-Chloro-1-(1-(5-(ethoxyme...)
Affinity DataIC50: 5.70E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477648(US10889569, Example 31 | 4-(1-(5-(Ethoxymethyl)-4-...)
Affinity DataIC50: 5.80E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477645(US10889569, Example 29 | 6-Fluoro-1-(1-(4-(6-metho...)
Affinity DataIC50: 6.20E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477647(US10889569, Example 30 | 6-Fluoro-1-(1-(5-(methoxy...)
Affinity DataIC50: 6.70E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477629(US10889569, Example 7 | 5-Fluoro-1-(1-(5-(methoxym...)
Affinity DataIC50: 6.70E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477625(US10889569, Example 3 | 1-(1-(4-(Benzo[d][1,3]diox...)
Affinity DataIC50: 7.00E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477641(US10889569, Example 22 | 8-Fluoro-4-(1-(5-(methoxy...)
Affinity DataIC50: 7.50E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477657(US10889569, Example 43 | 7-Fluoro-4-(1-(4-(6-metho...)
Affinity DataIC50: 7.90E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477647(US10889569, Example 30 | 6-Fluoro-1-(1-(5-(methoxy...)
Affinity DataIC50: 8.50E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477655(US10889569, Example 41 | (5-(3-(6-Fluoronaphthalen...)
Affinity DataIC50: 9.00E+3nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477659(US10889569, Example 27 | 1-(1-(4-(Benzo[d][1,3]dio...)
Affinity DataIC50: 9.10E+3nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477642(US10889569, Example 24 | 7-Fluoro-4-(1-(5-(methoxy...)
Affinity DataIC50: 1.07E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477635(US10889569, Example 14 | 6-Fluoro-3-(1-(5-(methoxy...)
Affinity DataIC50: 1.09E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477636(US10889569, Example 17 | 5-Fluoro-1-(1-(5-(methoxy...)
Affinity DataIC50: 1.09E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477635(US10889569, Example 14 | 6-Fluoro-3-(1-(5-(methoxy...)
Affinity DataIC50: 1.18E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477634(US10889569, Example 13 | 5-Fluoro-1-(1-(5-(methoxy...)
Affinity DataIC50: 1.19E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477645(US10889569, Example 29 | 6-Fluoro-1-(1-(4-(6-metho...)
Affinity DataIC50: 1.21E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1b receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477626(US10889569, Example 4 | 3-Chloro-1-(1-(5-(ethoxyme...)
Affinity DataIC50: 1.24E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477630(US10889569, Example 9 | 5-(3-(3-(6-Fluorobenzo[b]t...)
Affinity DataIC50: 1.25E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1b receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477659(US10889569, Example 27 | 1-(1-(4-(Benzo[d][1,3]dio...)
Affinity DataIC50: 1.39E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477650(US10889569, Example 35 | 4-(1-(5-(Difluoromethyl)-...)
Affinity DataIC50: 1.41E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477640(US10889569, Example 21 | 5-(3-(3-(7-Fluorobenzodih...)
Affinity DataIC50: 1.73E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477581(US10889569, Example 1 | 7-Fluoro-4-(1-(5-(methoxym...)
Affinity DataIC50: 1.81E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1b receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477636(US10889569, Example 17 | 5-Fluoro-1-(1-(5-(methoxy...)
Affinity DataIC50: 1.98E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1b receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477647(US10889569, Example 30 | 6-Fluoro-1-(1-(5-(methoxy...)
Affinity DataIC50: 2.07E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477626(US10889569, Example 4 | 3-Chloro-1-(1-(5-(ethoxyme...)
Affinity DataIC50: 2.07E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477649(US10889569, Example 32 | 7-Fluoro-4-(1-(4-(6-metho...)
Affinity DataIC50: 2.30E+4nMAssay Description:V1aR: The inhibition effect of the compounds of the present invention on the activity of human V1 aR protein expressed in HEK293/human V1aR stably tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477633(US10889569, Example 11 | 5-(3-(3-(6-Fluorobenzofur...)
Affinity DataIC50: 2.57E+4nMAssay Description:V2R: The inhibition effect of the compounds of the present invention on the activity of human V2R protein expressed in HEK293/human V2R cells was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1b receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477635(US10889569, Example 14 | 6-Fluoro-3-(1-(5-(methoxy...)
Affinity DataIC50: 2.58E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1b receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477624(US10889569, Example 2 | 5-(3-(3-(6-Fluoronaphthale...)
Affinity DataIC50: 2.60E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1b receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477640(US10889569, Example 21 | 5-(3-(3-(7-Fluorobenzodih...)
Affinity DataIC50: 3.88E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1b receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477630(US10889569, Example 9 | 5-(3-(3-(6-Fluorobenzo[b]t...)
Affinity DataIC50: 4.27E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetVasopressin V1b receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477642(US10889569, Example 24 | 7-Fluoro-4-(1-(5-(methoxy...)
Affinity DataIC50: 4.41E+4nMAssay Description:V1bR: The inhibition effect of the compounds of the present invention on the activity of human V1bR protein expressed in HEK293/human V1bR cells was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 62 total ) | Next | Last >>
Jump to: